Abstract:Because of the potential application of prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), Candida antarctica lipase B (CAL-B) catalyzed polycondensation of profen-containing diol monomers and diesters were designed to prepare a series of biodegradable polymeric prodrugs composed of NSAID branches and poly(amide-co-ester) backbone. The structure of the products was confirmed by Fourier transform infrared spectroscopy, NMR, and gel permeation chromatography (GPC). The reaction conditions of polymerization, such as the enzyme source, amount of catalyst, and temperature, were optimized. The molecular weights of resultant copolymers were 217013,270 g/mol, with corresponding polydispersities from 1.17 to 2.4. The copolymers had relatively high drug loadings of 44.759.7 wt % because every repeat unit contained one drug molecule. The strategy of enzymatic polymerization appeared to be quite general and accommodated a large number of comonomer substrates with various chain lengths and substituents. The optically pure (R)-naproxen monomer was demonstratively incorporated into the corresponding copolymers with the developed synthesis strategy. The in vitro study showed that the polyester could release the drug effectively under physiological conditions with enzyme, which indicated that the obtained product could be a promising prodrug for extending pharmacological effects by delayed drug release. With GPC analysis, we confirmed that the prodrug was completely degradable in aqueous solution. The attractive features of the copolymer were its high drug loading, biodegradability, and biocompatibility. The high tolerance of the CAL-B toward drug groups, as described in this article, provides a new route for synthesizing polymeric drugs with potential biomedical applications in mild conditions and for reducing environmental impact. (c) 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013

Synthesis of naproxen-oleylglycerol prodrug by nonaqueousphase enzyme-catalyzed reactions

Synthesis of Structured Lipid 1,3-Dioleoyl-2-palmitoylglycerol in Both Solvent and Solvent-Free System

Analysis of Regioselectivity of Lipases Using Acidolysis of Lauric Acid and Camellia Oil

Enzymatic Resolution of (S)-(+)-naproxen in A Trapped Aqueous-Organic Solvent Biphase Continuous Reactor

Surfactant effect on enhancing (S)-naproxen prodrug production from racemic naproxen by lipase

Enantioselective Hydrolysis of Naproxen Methyl Ester by Lipase in A Water-Saturated Ionic Liquid

Synthesis, Crystal Structure and Biological Activities of Naproxen-Eugenol Ester Prodrug

Chemo-enzymatic synthesis of optically active polymeric prodrug of naproxen, ketoprofen and ibuprofen

Lipase-catalyzed esterification in organic solvent to resolve racemic naproxen

[Enzymatic Resolution of Racemic Naproxen in a Low Aqueous-Organic Biphase System].

Experimental study on resolution of naproxen methyl esters in an emulsion enzyme membrane reactor

Dynamic Enzymatic Resolution of Naproxen Methyl Ester in a Membrane Bioreactor

The Preparation of Polymerizable, Optically Active Non-Steroidal Anti-Inflammatory Drugs Derivatives by Irreversible Enzymatic Methods

LIPASE-CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF KETOPROFEN IN ORGANIC MEDIA

Lipase‐catalyzed Synthesis of Polymeric Prodrugs of Nonsteroidal Anti‐inflammatory Drugs

Performance of an emulsion enzyme membrane reactor combined with premix membrane emulsification for lipase-catalyzed resolution of enantiomers

A Facile Method for Preparation of Polymerizable, Optically Active Ketoprofen Prodrug by Irreversible Lipase-catalysed Resolution

Efficient Production of (S)-Naproxen with (R)-Substrate Recycling Using an Overexpressed Carboxylesterase BsE-NP01.

Synthesis of Structured Phospholipids with Conjugated Linoleic Acid by Lipase - Catalyzed Acidolysis: Optimization Using Response Surface Methodology

Prolonged Naproxen Joint Residence Time after Intra-Articular Injection of Lipophilic Solutions Comprising a Naproxen Glycolamide Ester Prodrug in the Rat

Lipases as tools in the synthesis of prodrugs from racemic 9-(2,3-dihydroxypropyl)adenine